Director Roger Jeffs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director roger jeffs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Roger Jeffs Today - Breaking & Trending Today

Rhenman & Partners Asset Management AB Buys 39,000 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Rhenman & Partners Asset Management AB boosted its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 97.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 79,100 shares of the company’s stock after purchasing an additional 39,000 shares during the quarter. […] ....

United States , Roger Jeffs , Markl Jacobson , Axsome Therapeutics Inc , Washington Trust Advisors Inc , Sg Americas Securities , Cantor Fitzgerald , Royal Bank , Securities Exchange Commission , Morgan Stanley , Partners Asset Management , Axsome Therapeutics , Free Report , Trust Advisors , Ivy Capital Management , Aigen Investment Management , Director Roger Jeffs , Exchange Commission , Get Free Report , Visit Holdingschannel , Axsome Therapeutics Daily ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stake Boosted by Meridian Wealth Management LLC

Meridian Wealth Management LLC raised its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,498 shares of the company’s stock after purchasing an additional 1,275 shares during […] ....

United States , Roger Jeffs , Markl Jacobson , Robertw Baird , Meridian Wealth Management , Exchange Commission , Washington Trust Advisors Inc , Cantor Fitzgerald , Fifth Third Bancorp , Axsome Therapeutics Company Profile , Morgan Stanley , Axsome Therapeutics Inc , Third Bancorp , Sg Americas Securities , Royal Bank , Axsome Therapeutics , Free Report , Wealth Management , Trust Advisors , Ivy Capital Management , Therapeutics Trading Down , Get Free Report , Director Roger Jeffs , Visit Holdingschannel , Axsome Therapeutics Daily , Nasdaq Axsm ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Recommendation of "Moderate Buy" by Analysts

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Recommendation of "Moderate Buy" by Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

New Zealand General , New Zealand , United States , Robertw Baird , Markl Jacobson , Roger Jeffs , Axsome Therapeutics Inc , Phocas Financial Corp , Wellington Management Group , Victory Capital Management Inc , Securities Exchange Commission , Kennedy Capital Management , Royal Bank , Axsome Therapeutics , Get Free Report , Marketbeat Ratings , Director Roger Jeffs , Exchange Commission , Capital Management , Management Group , Phocas Financial , Get Free , Axsome Therapeutics Daily ,

Axsome Therapeutics (NASDAQ:AXSM) Given New $106.00 Price Target at Mizuho

Axsome Therapeutics (NASDAQ:AXSM) Given New $106.00 Price Target at Mizuho
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Roger Jeffs , Piper Sandler , Markl Jacobson , Securities Exchange Commission , Covestor Ltd , Russell Investments Group Ltd , Axsome Therapeutics Inc , Washington Trust Advisors Inc , Cantor Fitzgerald , Fifth Third Bancorp , Third Bancorp , China Universal Asset Management Co , Royal Bank , Axsome Therapeutics , Free Report , Moderate Buy , Therapeutics Trading Down , Get Free Report , Exchange Commission , Director Roger Jeffs , Trust Advisors , Investments Group , Universal Asset Management , Axsome Therapeutics Daily ,

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $112.00

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $112.00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Robertw Baird , Roger Jeffs , Markl Jacobson , Securities Exchange Commission , Axsome Therapeutics Company Profile , Russell Investments Group Ltd , Cantor Fitzgerald , Morgan Stanley , Axsome Therapeutics Inc , Washington Trust Advisors Inc , Third Bancorp , Fifth Third Bancorp , China Universal Asset Management Co , Janiczek Wealth Management , Axsome Therapeutics , Free Report , Moderate Buy , Therapeutics Stock Down , Get Free Report , Exchange Commission , Director Roger Jeffs , Trust Advisors , Investments Group , Universal Asset Management , Axsome Therapeutics Daily ,